About RECapp

Patients diagnosed with oesophageal or gastric cancer undergo extensive surgery for a chance of cure. Recovery after surgery is usually long, challenging, and quality of life is often reduced. It is therefore crucial to develop interventions that can reduce symptom burden and improve the quality of life of affected patients.

 

The Surgical Care Science research group has collaborated closely with patients treated for oesophageal and gastric cancer over many years. Affected patients have continually emphasised the importance of, and need for, personalised support after treatment.

​

In collaboration with partners and key stakeholders across Sweden (such as hospitals, the patient organisation PALEMA, the quality registry NREV, and National care program group for oesophageal and gastric cancer), we will test and evaluate RECapp, where patients who have undergone surgery will be monitored for symptoms in their home and guided to self-care advice or contact with healthcare services.

​

The study is planned to start in the spring of 2025.